Isolated corticotropin releasing factor derivatives, and nucleic acids encoding the same, are effective for treating corticotropin releasing factor 2 receptor modulated disorders such as muscular dystrophy.
Web www.patentalert.com
< Nano-mechanic microsensors and methods for detecting target analytes
< Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
> Cerberus/Coco derivatives and uses thereof
> Compositions comprising amphotericin B, methods, and systems
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT